Announced Tue, 14 Apr · 17:02 IST
Compliance certificate under SEBI (DP) Regulations 2018
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+13.3%1-day move
₹7.15
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+13.3+4.9+8.7+3.4+5.5+11.6+10.5+8.4+3.4+4.6
Up moveDown movePending
AI summary
Vista Pharmaceuticals has submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This is a routine quarterly filing confirming that the company's Registrar and Transfer Agent has processed dematerialisation and rematerialisation requests and handled securities certificates as per SEBI norms. The filing is procedural and carries no material business or financial information.
Likely market impact
Routine regulatory compliance filing with no expected impact on stock price or shareholders.